High SVR@ rates were achieved irrespective of the use of ribavirin or extension of the treatment duration from @ to @ weeks ; SVR@ rates ranged from @ % ( @ % CI @-@ ; @/@ ; cohort @ , @ weeks , ribavirin-containing ) to @ % ( @ % CI @-@ ; @/@ ; cohort @ , @ weeks , ribavirin-containing ) .